Epicardial gene therapy and laser revascularization

Current Cardiology Reports

Volumn 1, Issue 4, 1999, Pages 335-343

  Symes, James F ^a  

^a ST ELIZABETH'S MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL CELL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; LYMPHOKINE; VASCULOTROPIN; VASCULOTROPIN A;

ANIMAL; CORONARY ARTERY DISEASE; COST BENEFIT ANALYSIS; GENE THERAPY; GENETIC TRANSFECTION; HEART MUSCLE REVASCULARIZATION; HUMAN; INTRADERMAL DRUG ADMINISTRATION; LASER SURGERY; METHODOLOGY; MULTIMODALITY CANCER THERAPY; PERICARDIUM; REVIEW;

ADMINISTRATION, CUTANEOUS; ANIMALS; COMBINED MODALITY THERAPY; CORONARY DISEASE; COST-BENEFIT ANALYSIS; ENDOTHELIAL GROWTH FACTORS; FIBROBLAST GROWTH FACTORS; GENE THERAPY; HUMANS; LASER SURGERY; LYMPHOKINES; MYOCARDIAL REVASCULARIZATION; PERICARDIUM; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0033223062     PISSN: 15233782     EISSN: 15343170     Source Type: Journal    
DOI: 10.1007/s11886-999-0060-6     Document Type: Article

References (57)

1. Favaloro RG: Saphenous vein graft in the surgical treatment of coronary artery disease. J Thorac Cardiovasc Surg 1969, 58:178-185.
2. Wearn JT, Mettler SR, Klumpp TG, et al.: The nature of the vascular communications between the coronary arteries and the chambers of the heart. Am Heart J 1933, 9:143-164.
3. Sen PK, Udwadia TE, Kinare SG, et al.: Transmyocardial acupuncture, a new approach to myocardial revascularization. J Thorac Cardiovasc Surg 1965, 50:181-189.
4. Mirosheini M, Clayton MM: Revascularization of the heart by laser. J Microsurg 1981, 2:253-260.
5. March RJ: Transmyocardial Laser Revascularization with the CO2 laser: One year results of a randomized, controlled trial. Seminars in Thoracic and Cardiovasc Surg 1999, 11: 12-18.
6. Kantor B, McKenna CJ, Caccitolo JA, et al.: Transmyocardial and percutaneous myocardial revascularization: Current and future role in the treatment of coronary artery disease. Mayo Clinic Proc 1999, 74:585-592.
7. Hughes GC, Kypson A P, St. Louis JD, et al.: Improved perfusion and contractile reserve after transmyocardial laser revascularization in a model of hibernating myocardium. Ann Thor Surg 1999, 67 1714-1720.
8. Horvath KA, Greene R, Belkind N, et al.: Left ventricular functional improvement after transmyocardial laser revascularization. Ann Thor Surg 1998, 66:721-725.
9. Allen KB, Fudge TL, Schoettle P Jr, et al.: Prospective randomized multicenter trial of transmyocardial revascularization versus maximal medical management in patients with refractory class IV angina: 12-month results [abstract]. Circulation 1998, 98(Suppl I):I-476.
10. Jones WJ, Schmidt SE, Richman BW, et al.: Holmium: YAG laser transmyocardial revascularization relieves angina and improves functional status. Ann Thorac Surg 1999, 67:1596-1602.
11. Schofield PM, Sharples LD, Caine N, et al.: Transmyocardial laser revascularization in patients with refractory angina a randomized controlled trial. Lancet 1999, 353:519-524.
12. Moosdorf R: Transmyocardial laser revascularization [letter] Lancet 1999, 353-1705.
13. Lutter G, Saurbier B, Nitzsche E, et al.: Transmyocardial laser revascularization (TMLR) in patients with unstable angina and low ejection fraction. Eur J Cardiothorac Surg 1998, 13(1):21-26.
14. Nagele H, Stubbe HM, Nienaber C, et al.: Results of transmyocardial laser revascularization in non revascularizable coro nary artery disease after 3 years follow up. Eur Heart J 1998, 19(10): 1525-1530.
15. Krabatsch T, Schaper F, Leder C, et al.: Histological findings after transmyocardial laser revascularization. J Card Surg 1996, 11-326-331.
16. Sigel JE, Abramovich CM, Lytle BW, et al.: Transmyocardial laser revascularization: Three sequential autopsy cases. J Thor Cardiov Surg 1998, 115:1381-1384.
17. Fisher PE, Khomoto T, DeRosa CM, et al.: Histologic analysis of transmyocardial channels: Comparison of CO2 and holmium: YAG lasers. Ann Thor Surg. 1997, 64:466-742.
18. Kohmoto T, Fisher PE, Gu A, et al.: Does blood flow through holmium: YAG transmyocardial laser channels? Ann Thor Surg 1996, 61:861-868.
19. Malekan R, Reynolds C, Narula N, et al.: Angiogenesis in transmyocardial laser revascularization: A nonspecific response to injury. Circulation 1998, 98:II-62-66.
20. Hughes GC, Lowe JE, Kypson AP, et al.: Neovascularization after transmyocardial laser revascularization in a model of chronic ischemia. Ann Thor Surg 1998, 66:2029-2036.
21. Mueller XM, Tevaearai HT, Genton CY, et al.: Are there vascular density gradients along myocardial laser channels? Ann Thor Surg 1999, 68:125-130.
22. Yamamoto N, Kohmoto T, Gu A, et al.: Angiogenesis is enhanced in ischemic canine myocardium by transmyocardial laser revas cularization. J Am Coll Cardiol 1998, 31:1426-1433.
23. Kwong KF, Kanellopoulos GK, Nickols JC, et al.: Transmyocardial laser treatment denervates canine myocardium. J Thor Cardiov Surg 1997, 114:883-890.
24. Hughes GC, Landolfo KP, Lowe JE, et al.: Diagnosis, incidence, and clinical significance of early postoperative ischemia after transmyocardial laser revascularization. Am Heart J 1999, 137 1163-1168.
25. Al-Sheikh T, Allen KB, Straka SP, et al.: Cardiac sympathetic denervation after transmyocardial laser revascularization. Circulation 1999, 100:135-140.
26. Kwong KF, Schuessler RB, Kanellopoulos GK, et al.: Nontransmural laser treatment incompletely denervates canine mycar dium. Circulation 1998, 98 II-67-72.
27. Chu V, Giaid A, Kuang J, et al.: Angiogenic response in transmyocardial revascularization: Comparison of laser vs. mechanical punctures. Ann Thor Surg 1999, 68:301-308.
28. Chu V, Kuang J, McGinn A, et al.: Mechanical transmyocardial revascularization induced angiogenic response. J Thor Cardiov Surg 1999, in press.
29. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995, 1:27-31.
30. Melillo G, Scoccianti M, Kovesdi I, et al.: Gene therapy for collateral vessel development. Cardiov Res 1997, 35:480-489.
31. Lee LY, Rosengart TK: Transmyocardial laser revascularization and angiogenesis: The potential for therapeutic benefit. Seminars in Thor Cardiov Surg 1999, 11:29-35.
32. Rosengart TK, Patel S, Crystal RG: Therapeutic angiogenesis: protein and gene therapy delivery strategies. J Cardiovas Risk 1999, 6:29-40.
33. Connolly DT: Vascular permeability factor: A unique regula tor of blood vessel function. J Cell Bioche 1991, 47 219-223.
34. Asahara T, Bauters C, Zheng LP, et al.: Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation 1995, 92:II-365-371.
35. Pepper MS, Ferrara N, Orci L, et al.: Potent synergism between vascular endothelial growth factor and fibroblast growth factor in the induction of angiogenesis in vitro. Biochem Biophys Res Commun 1992, 189:824-831.
36. Semenza GL: Transcriptional regulation by hypoxia inducible factor l-molecular mechanisms of oxygen homeostasis. Trends Cardiovasc Med 1996, 6:151-157.
37. Pu L, Lachapelle K, Graham A, et al.: Angiogenic stimulation: a new approach for severe chronic limb ischemia. Surg Forum 1991, XLII:365-367.
38. Harada K, Friedman M, Lopez JJ, et al.: Vascular endothelial growth factor in chronic myocardial ischemia. Am J Physiol 1996, 270:H1791-H1802.
39. Hariawala M, Horowitz JR, Esakof D, et al.: VEGF improves myocardial blood flow but produces EDRF mediated hypotension in porcine hearts. J Surg Res 1996, 63:77-82.
40. Selke F Li J, Stamler A, et al.: Angiogenesis induced by acidic fibroblast growth factor as an alternative method of revascularization for chronic myocardial ischemia. Surgery 1996, 120:182-188.
41. Tsurumi Y, Takeshita S, Chen D, et al.: Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissu perfusion. Circulation 1996, 98:I-526.
42. Tio RA, Lebherz C, Scheuermann TH Jr, et al.: Intramyocardial injection with naked DNA encoding for VEGF causes local and systemic production of VEGF, and improves collateral flow to ischemic myocardial tissue. Circulation 1998, 98:I-526.
43. Lee LY, Zhou X, Polce DR, et al.: Exogenous control of cardiac gene therapy: Evidence of regulated myocardial transgene expression after adenovirus and adeno associated virus trans fer of expression cassettes containing corticosteroid respons element promoters. J Thorac Cardiov Surg. 1999, 118:26-35.
44. Laham RJ, Leimbach M, Chronos NA, et al.: Intracoronary administration of recombinant fibroblast growth factor 2 (rFGF 2) in patients with severe coronary artery disease: Results of Phase I. JACC 1999, 33:383A.
45. Henry TD, Annex BH, Azrin MA, et al.: Double blind, placebo controlled trial of recombinant human vascular endothelial growth factor - The VIVA trial. JACC 1999, 33 384A.
46. Schumacher B, Pecher P, von Specht BU, et al.: Induction of neoangiogenesis in ischemic myocardium by human growth factors First clinical results of a new treatment of coronary heart disease. Circulation 1998, 97:645-650.
47. Rosengart TK, Lee LY, Patel SR, et al.: Angiogenesis gene therapy: Phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. Circulation 1999, 100: 468-474.
48. Symes JF, Losordo DW, Vale PR, et al.: Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease. Ann Thor Surg 1999, in press.
49. Kornowski R, Bhargava B, Leon M: Percutaneous transmyocardial laser revascularization: An overview. Cathet Cardiovasc Intervent 1999, 47:354-359.
50. Vale PR, Losordo DW, Tkebuchava T, et al.: Catheter-based myocardial gene transfer utilizing nonfluoroscopic electromechanical left ventricular mapping. JACC 1999, 34:246-254.
51. Sayeed-Shah U, Mann MJ, Martin J, et al.: Complete reversal of ischemic wall motion abnormalities by combined use of gene therapy with transmyocardial laser revascularization. J Thorac Cardiovasc Surg 1998, 116:763-769.
52. Yamamoto N, Kohmoto T, Gu A, et al.: Basic fibroblast growth factor enhances the angiogenic effects of transmyocardial laser revascularization. Circulation 1998, 98:I-217.
53. Hughes C, Annex B, Yin B, et al.: Transmyocardial laser revascularization (TMR) limits in vivo adenoviral-mediated gen transfer in porcine myocardium JACC 1999, 33:355A.
54. Allen KB, Delrossi AJ, Lefrak EA, et al.: Transmyocardial revascularization combined with coronary artery bypass grafting versus coronary artery bypass grafting alone: Results of a prospective randomized, multi-center trial. Circulation 1998, 98:I-217.
55. Trehan N, Mishra Y, Mehta Y, et al.: Transmyocardial laser as an adjunct to minimally invasive CABG for complete myocardial revascularization. Ann Thor Surg 1998, 66:1113-1118.
56. Sellke FW, Laham RJ, Edelman ER, et al.: Therapeutic angiogenesis with basic fibroblast growth factor: Technique and early results. Ann Thor Surg 1998, 1540-1544.
57. Burkhoff D, Wesley MN, Resar JR, et al.: Factors correlating with risk of mortality after transmyocardial revascularization. J Am Coll Cardiol 1999, 34:55-61.